XI’AN, China, April 07, 2025 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a prominent provider of bio-ingredient solutions for the natural health and personal care sectors, today announced a significant breakthrough. Between October 2024 and January 2025, the company achieved industry-leading yields of 12-16% in the bio-manufacturing of tea pigments, while maintaining purity levels above 95%.
Tea pigments have demonstrated considerable biological properties, including the ability to lower lipids and blood glucose, provide antioxidant effects, and combat peptic ulcers, making them widely applicable across various health industries. Recognized as the most promising functional tea derivative since the commercialization of tea polyphenols, tea pigments show especially strong potential for growth in digestive wellness and blood glucose management applications. According to data from the Tea Pigments Research Institute and market research firms, the global tea pigment industry is projected to exceed $12 billion by 2025. Furthermore, the abundant availability of raw materials from tea positions this as a potentially groundbreaking innovative application.
Yongwei Hu, CEO & Chairman of Bon, commented, “Our company will actively pursue innovative formulations of tea pigment-based products, targeting innovative applications in gastrointestinal and metabolic health through strategic partnerships. We are very optimistic about collaborating with forward-thinking entities in nutrition science and preventive healthcare to accelerate the market development of next-generation tea-based solutions.”
1Data from 2025-2030 China Tea Pigments Industry Development Research Report
About Bon Natural Life Limited (“BON”)
BON, a Cayman Islands-based company, operates in the natural health and personal care industries. More information is available on the Company’s website at http://www.bnlus.com.
For more information, please contact:
Cindy Liu | IR
Email: bonnatural@appchem.cn
Safe Harbor Statement
This release contains statements that may be considered “forward-looking statements.” These statements, which are not based on historical facts, are often identified by terms like “believes,” “expects,” or similar expressions and involve known and unknown risks and uncertainties. While the Company believes its expectations are reasonable, these forward-looking statements involve assumptions, risks, and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on these statements, which are relevant only as of the release date. Factors that could cause actual results to differ include those discussed in the Company’s filings with the Securities and Exchange Commission, available on its website (http://www.sec.gov). All forward-looking statements made by the Company or its representatives are qualified in their entirety by these factors. The Company undertakes no obligation to update these statements, except as required by securities laws.
